No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
ACCD Accolade
- 9.210
- +0.080+0.88%
Close Apr 22 16:00 ET
- 8.860
- -0.350-3.80%
Post 16:10 ET
712.92MMarket Cap-5685P/E (TTM)
9.370High8.745Low651.87KVolume9.020Open9.130Pre Close5.97MTurnover0.94%Turnover RatioLossP/E (Static)77.41MShares15.36052wk High1.64P/B641.40MFloat Cap6.33052wk Low--Dividend TTM69.64MShs Float65.250Historical High--Div YieldTTM6.85%Amplitude4.610Historical Low9.157Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Alphabet To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Susquehanna
Accolade Is Maintained at Buy by Stifel
Accolade Is Maintained at Buy by Stifel
Accolade Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/22/2024 42.39% Stifel $15 → $13 Maintains Buy 02/26/2024 75.25% Leerink Partners → $16 Initiates Covera
Express News | Accolade Inc : Stifel Cuts Target Price to $13 From $15
Accolade to Announce Fiscal Fourth Quarter 2024 Financial Results
PDF Version SEATTLE, April 03, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal fourth quarter 2024 financial results on Thursday, April 25, 2024
Recent Uptick Might Appease Accolade, Inc. (NASDAQ:ACCD) Institutional Owners After Losing 24% Over the Past Year
Comments
Accolade's balance sheet seems manageable with its US$741.6m market cap, but needs monitoring. Its future profitability will impact its financial strength. However, its EBIT loss, negative free cash outflow of US$37m, and a US$123m accounting loss make it somewhat risky.
Health Check: How Prudently Does Accolade (NASDAQ:ACCD) Use Debt? 1
Investors seem to be banking on Accolade's strong future outlook, despite its slow growth in revenue. The high P/S ratio and share price suggest confidence in the company's future revenues.
ColumnsToday's pre-market stock movers: KSS, NIO, MU, LULU and more
Gainers:
• $Cytokinetics(CYTK.US$ +8.7% (prices offering of of $450.0 mln of 3.50% convertible senior notes due 2027)
• $XPeng(XPEV.US$ +3.4% (June deliveries)
• $NIO Inc(NIO.US$ +2.9% (June deliveries)
• $Bitfarms(BITF.US$ +2.7% (provides June 2022 production and mining operations update)
• $Accolade(ACCD.US$ +2.7% (In reaction to earnings/guidance)
• $BioCryst Pharmaceuticals(BCRX.US$ +2.6% (presents new data demonstrating...
• $Cytokinetics(CYTK.US$ +8.7% (prices offering of of $450.0 mln of 3.50% convertible senior notes due 2027)
• $XPeng(XPEV.US$ +3.4% (June deliveries)
• $NIO Inc(NIO.US$ +2.9% (June deliveries)
• $Bitfarms(BITF.US$ +2.7% (provides June 2022 production and mining operations update)
• $Accolade(ACCD.US$ +2.7% (In reaction to earnings/guidance)
• $BioCryst Pharmaceuticals(BCRX.US$ +2.6% (presents new data demonstrating...
18
1
ColumnsTop upgrades and downgrades on 5/2
Upgrades
• $Accolade(ACCD.US$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $6 (from $9)
• $Comerica(CMA.US$ : Piper Sandler Upgrades to Overweight from Neutral - PT $94 (from $90)
• $New Oriental(EDU.US$ : JPMorgan Upgrades to Neutral from Underweight - PT $14 (from $35)
• $EPAM Systems(EPAM.US$ : Piper Sandler Upgrades to Overweight from Neutral - PT $348 (from $359)
• $Empire State Realty Trust Inc(ESRT.US$ : Evercore ISI Upgrades to Outp...
• $Accolade(ACCD.US$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $6 (from $9)
• $Comerica(CMA.US$ : Piper Sandler Upgrades to Overweight from Neutral - PT $94 (from $90)
• $New Oriental(EDU.US$ : JPMorgan Upgrades to Neutral from Underweight - PT $14 (from $35)
• $EPAM Systems(EPAM.US$ : Piper Sandler Upgrades to Overweight from Neutral - PT $348 (from $359)
• $Empire State Realty Trust Inc(ESRT.US$ : Evercore ISI Upgrades to Outp...
18
1
thank youColumnsToday's pre-market stock movers: AMZN, AAPL, MA, CVX and more
Gainers:
• $GTY Technology(GTYH.US$ +118.1% (entered into a definitive agreement to be acquired by GI Partners )
• $Finch Therapeutics(FNCH.US$ +68.33% (announces removal of FDA clinical hold on CP101 IND)
• $Zymeworks(ZYME.US$ +42.34% (confirms receipt of non-binding proposal from All Blue Falcons for $10.50 per share in cash)
• $Hub Group(HUBG.US$ +16.3% (earnings reports)
• $Lantheus(LNTH.US$ +14.2% (earnings reports)
• $Mohawk Industries(MHK.US$ +13.7% (e...
• $GTY Technology(GTYH.US$ +118.1% (entered into a definitive agreement to be acquired by GI Partners )
• $Finch Therapeutics(FNCH.US$ +68.33% (announces removal of FDA clinical hold on CP101 IND)
• $Zymeworks(ZYME.US$ +42.34% (confirms receipt of non-binding proposal from All Blue Falcons for $10.50 per share in cash)
• $Hub Group(HUBG.US$ +16.3% (earnings reports)
• $Lantheus(LNTH.US$ +14.2% (earnings reports)
• $Mohawk Industries(MHK.US$ +13.7% (e...
18
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg